Click here to learn What's New at our website. Page views in 13, Cite this page: Weisenberg E Amebic colitis. Accessed June 4th, Infection by pathogenic species of amebae, overwhelmingly Entamoeba histolytica.
|Published (Last):||1 August 2007|
|PDF File Size:||5.49 Mb|
|ePub File Size:||13.68 Mb|
|Price:||Free* [*Free Regsitration Required]|
Amebiasis in the epidemiologic transition in Mexico: its morbidity and mortality trends in the Mexican Institute of Social Security.
Arch Med Res. Mortimer L, Chadee K. The immunopathogenesis of Entamoeba histolytica. Exp Parasitol. Roles and regulation of the mucus barrier in the gut.
Tissue barriers. Stanley SL Jr. Protective immunity to amebiasis: new insights and new challenges. J Infect Dis. Seroepidemiology of amebiasis in Mexico. Am J Trop Med Hyg. Human amebiasis: breaking the paradigm? Baxt LA, Singh U. New insights into Entamoeba histolytica pathogenesis.
Curr Opin Infect Dis. Amebic colitis: New insights into pathogenesis and treatment. Curr Gastroenterol Rep. Host-parasite interactions in Entamoeba histolytica and Entamoeba dispar: what have we learned from their genomes? Parasite Immunol. Morf L, Singh U. Entamoeba histolytica: a snapshot of current research and methods for genetic analysis.
Curr Opin Microbiol. Laboratory diagnosis of amebiasis. Clin Microbiol Rev. Invasive amoebiasis: a review of Entamoeba infections highlighted with case reports. Can J Gastroenterol Hepatol. Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex. BMC infectious diseases. Keefe DM.
Intestinal mucositis: mechanisms and management. Current opinion in oncology. Castellanos Galan JE. Amebiasis intestinal en pacientes con leucemia aguda de novo. UNAM, Laboratory diagnostic techniques for Entamoeba species.
Clinical microbiology reviews. Rapid diagnosis of intestinal parasitic protozoa, with a focus on Entamoeba histolytica. Interdisciplinary perspectives on infectious diseases ; Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: update by the infectious diseases society of america. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America.
Practice guidelines for the management of infectious diarrhea. Clinical Infectious Diseases.
Amebiasis (disentería amebiana)
We'd like to understand how you use our websites in order to improve them. Register your interest. Amebiasis is the acute and chronic disease produced by Entamoeba histolytica , an entity which occurs in endemic fashion in many of the tropical and subtropical areas of the world, capable of affecting diverse organs of the body, especially the colon. Amebiasis has different clinical forms of presentation, varying from the asymptomatic carrier state to severe, although not frequent, fulminant or necrotizing colitis, characteristically associated with high morbidity and mortality. Early diagnosis, treatment with effective antiamebic agents—specifically metronidazole—and opportune aggressive surgical intervention have resulted in better survival rates.
Fulminant amebic colitis